Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivo-Reference-Cited by-同舟云学术

Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivo

Published:2016-05-07 Issue:28 Volume:7 Page:43267-43280
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Blaeschke Franziska¹²,Thiel Uwe¹,Kirschner Andreas¹,Thiede Melanie¹,Rubio Rebeca Alba³,Schirmer David¹,Kirchner Thomas³⁴⁵,Richter Gunther H.S.¹,Mall Sabine⁶,Klar Richard⁶,Riddell Stanley⁷,Busch Dirk H.⁸⁹,Krackhardt Angela⁶,Grunewald Thomas G.P.³⁴⁵,Burdach Stefan¹¹⁰

Affiliation:

1. Laboratory for Functional Genomics and Transplantation Biology, Department of Pediatrics and Children's Cancer Research Center, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany

2. Present address: Laboratory for Immunotherapy, Dr. von Hauner Children's Hospital, LMU München, Munich, Germany

3. Laboratory for Pediatric Sarcoma Biology, Institute of Pathology of the LMU Munich, Munich, Germany

4. German Cancer Consortium (DKTK), Heidelberg, Germany

5. German Cancer Research Center, Heidelberg, Germany

6. Medizinische Klinik III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

7. Department of Medicine, University of Washington, Seattle, WA, USA

8. Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen, München, Germany

9. Focus Group “Clinical Cell Processing and Purification”, Institute for Advanced Study, Technische Universität München, Munich, Germany

10. Munich Comprehensive Cancer Center (CCC), Klinikum rechts der Isar, Technische Universität München, Munich, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model;Frontiers in Immunology;2024-01-22

2. Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field;Cancers;2023-08-16

3. Targeted Therapy for EWS-FLI1 in Ewing Sarcoma;Cancers;2023-08-09

4. Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype;Biomedicines;2023-03-13

5. The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma;Clinical Cancer Research;2023-03-09